- Home
- EPAM vs TECH Comparison
EPAM vs TECH Comparison
Compare EPAM & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAM
- TECH
- Stock Information
- Founded
- EPAM 1993
- TECH 1976
- Country
- EPAM United States
- TECH United States
- Employees
- EPAM 53150
- TECH N/A
- Industry
- EPAM EDP Services
- TECH Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EPAM Technology
- TECH Health Care
- Exchange
- EPAM Nasdaq
- TECH Nasdaq
- Market Cap
- EPAM 13.3B
- TECH 11.3B
- IPO Year
- EPAM 2012
- TECH 1989
- Fundamental
- Price
- EPAM $234.69
- TECH $68.72
- Analyst Decision
- EPAM Buy
- TECH Buy
- Analyst Count
- EPAM 21
- TECH 9
- Target Price
- EPAM $263.75
- TECH $81.78
- AVG Volume (30 Days)
- EPAM 673.4K
- TECH 1.2M
- Earning Date
- EPAM 11-07-2024
- TECH 10-30-2024
- Dividend Yield
- EPAM N/A
- TECH 0.47%
- EPS Growth
- EPAM N/A
- TECH N/A
- EPS
- EPAM 7.70
- TECH 0.95
- Revenue
- EPAM $4,636,846,000.00
- TECH $1,171,583,000.00
- Revenue This Year
- EPAM $1.31
- TECH $7.67
- Revenue Next Year
- EPAM $8.71
- TECH $9.38
- P/E Ratio
- EPAM $30.42
- TECH $72.05
- Revenue Growth
- EPAM N/A
- TECH 2.41
- 52 Week Low
- EPAM $169.43
- TECH $61.16
- 52 Week High
- EPAM $317.50
- TECH $85.57
- Technical
- Relative Strength Index (RSI)
- EPAM 64.08
- TECH 41.02
- Support Level
- EPAM $187.64
- TECH $65.99
- Resistance Level
- EPAM $249.50
- TECH $76.43
- Average True Range (ATR)
- EPAM 6.82
- TECH 2.71
- MACD
- EPAM 1.51
- TECH -0.85
- Stochastic Oscillator
- EPAM 76.05
- TECH 19.25
About EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.
About TECH Bio-Techne Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.